GLSI
Greenwich LifeSciences, Inc. - Common stock (GLSI)
$79
About Greenwich LifeSciences, Inc. - Common stock (GLSI)
Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.
Details
Daily high
$17.32
Daily low
$15.40
Price at open
--
52 Week High
$34.10
52 Week Low
$7.78
Market cap
248.2M
Dividend yield
-
Volume
26
Avg. volume
122,156
P/E ratio
-11.15
Greenwich LifeSciences, Inc. - Common stock News
Details
Daily high
$17.32
Daily low
$15.40
Price at open
--
52 Week High
$34.10
52 Week Low
$7.78
Market cap
248.2M
Dividend yield
-
Volume
26
Avg. volume
122,156
P/E ratio
-11.15